Sui Guo-Ping, Pan Kai-Feng, Zhou Tong, Zhang Lian, Li Jia-Fu, Xu Guang-Wei
Department of Surgery, Peking University School of Oncology, Beijing Cancer Hospital, Beijing 100036, China.
Zhonghua Yi Xue Za Zhi. 2003 Sep 10;83(17):1479-83.
To investigate the correlation between polymorphisms of interleukin-1beta and RN genes and risk of gastric carcinoma.
PCR and denaturing high-performance liquid chromatography (DHPLC) were used to analyze the IL-1beta-31 and -511 C/T polymorphisms and to genotype the IL-1RN penta-allelic variable number of tandem repeats (VNTR): of the DNA from the peripheral blood of 143 patients of gastric carcinoma, 97 from Linqu County, Shandong Province, and 46 cases from the specimen bank of Beijing Cancer Hospital, and 337 controls without gastric carcinoma from Linqu County, most of which suffered from other gastric diseases.
IL-1-511 polymorphisms (carriers of IL-1beta-511T) were correlated with the increased risk of interstitial gastric carcinoma in both sexes (OR = 3.833, 95% CI: 2.282 approximately 6.439) and increased risk of diffuse gastric carcinoma in males (OR = 3.464, 95% CI: 1.394 approximately 8.608). The frequencies of IL-1beta-31 polymorphisms and IL-1IRN VNTR were not different between the gastric carcinoma group and the control group, IL-1beta-511 T carrier could be seen in the controls at different precancerous stages, for chronic atrophic gastritis (OR = 5.164, 95% CI: 2.661 approximately 10022), for interstitial metaplasia (OR = 5.093, 95% CI: 2.708 approximately 9.463), and for dysphasia (OR = 8.438, 95% CI: 3.939 approximately 18.073).
IL-1beta-31 genotypes and. IL-2RN VNTR do not increase the risk of gastric carcinoma. The IL-1beta-511 T genotype increases the risk of gastric carcinoma in every precancerous stage.
研究白细胞介素-1β(IL-1β)和白细胞介素-1受体拮抗剂(IL-1RN)基因多态性与胃癌风险之间的相关性。
采用聚合酶链反应(PCR)和变性高效液相色谱法(DHPLC)分析IL-1β -31和-511 C/T多态性,并对143例胃癌患者(其中97例来自山东省临朐县,46例来自北京肿瘤医院标本库)及337例临朐县无胃癌对照者(多数患有其他胃部疾病)外周血DNA中的IL-1RN五等位基因串联重复序列(VNTR)进行基因分型。
IL-1 -511多态性(IL-1β -511T携带者)与两性间弥漫性胃癌风险增加相关(比值比[OR]=3.833,95%可信区间[CI]:2.282至6.439),且与男性弥漫性胃癌风险增加相关(OR = 3.464,95% CI:1.394至8.608)。胃癌组与对照组之间IL-1β -31多态性频率和IL-1RN VNTR无差异,在不同癌前阶段的对照组中均可发现IL-1β -511 T携带者,慢性萎缩性胃炎(OR = 5.164,95% CI:2.661至10.022)、肠化生(OR = 5.093,95% CI:2.708至9.463)和发育异常(OR = 8.438,95% CI:3.939至18.073)。
IL-1β -31基因型和IL-1RN VNTR不会增加胃癌风险。IL-1β -511 T基因型在每个癌前阶段都会增加胃癌风险。